By: Khagesh KG
May 7 2020
False: Hydroxychloroquine is being used for compassionate treatment in the United Kingdom.
Share Article:
Fact-Check
The Verdict False
The MHRA guidance has stated that chloroquine and hydroxychloroquine are not licensed for use in COVID-19 treatment.
Claim ID 51d514df
The MHRA guidance has stated that chloroquine and hydroxychloroquine are not licensed for use in COVID-19 treatment.The Medicines and Healthcare products Regulatory Agency (MHRA) has said that Chloroquine and hydroxychloroquine are not licensed to treat symptoms of COVID-19 or prevent infection. It added that Clinical trials are ongoing to test the drugs like an agent in the treatment of COVID-19. The trials are incomplete, and hence the drugs cannot be used in the safe and effective treatment of COVID -19 patients. A local NHS Foundation Trust, Camden and Islington for example, has said the same in its news release. It has not been approved for compassionate use either. The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.